Atlas Trials

Allo HSCT Using RIC for Hematological Diseases

Clinical trial NCT02661035 · COMPLETED

Trial details

NCT number
NCT02661035
Sponsor
Masonic Cancer Center, University of Minnesota
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous LeukemiaPlasma Cell LeukemiaMyelodysplastic SyndromesChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaB-Cell LymphomaFollicular LymphomaLymphoplasmacytic LymphomaMantle-Cell LymphomaProlymphocytic Leukemia
Start date
2017-03-09
Primary completion
2023-04-17
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.